Literature DB >> 6436893

Influence of naloxone on antidepressant drug effects in the forced swimming test in mice.

J L Devoize, F Rigal, A Eschalier, J F Trolese, M Renoux.   

Abstract

The influence of naloxone on the effects of several antidepressant drugs, atropine and caffeine was studied in the forced swimming test in mice. Naloxone itself has no effect in this test, but significantly reduces that of two tricyclic antidepressants, clomipramine (20 and 30 mg/kg) and desipramine (20 and 30 mg/kg). Except for clorgyline at the high dose of 60 mg/kg, no significant reduction of activity by naloxone was observed with other antidepressants (pargyline, nomifensine and mianserin), nor with caffeine and atropine. These results are discussed in terms of the pharmacological characteristics of each drug and of the test used. No straightforward interaction between cholinergic or monoaminergic and endorphinic systems is evident. Possible action at opiate receptor sites is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436893     DOI: 10.1007/bf00432028

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Action of serotoninmimetics in the behavioral despair test in rats.

Authors:  Z Górka; E Wojtasik; H Kwiatek; J Maj
Journal:  Commun Psychopharmacol       Date:  1979

2.  The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations.

Authors:  J C Lai; T K Leung; J F Guest; L Lim; A N Davison
Journal:  Biochem Pharmacol       Date:  1980-10-15       Impact factor: 5.858

3.  Antidepressants and pain: a review of the pharmacological data supporting the use of certain tricyclics in chronic pain.

Authors:  R Lee; P S Spencer
Journal:  J Int Med Res       Date:  1977       Impact factor: 1.671

4.  An open and double-blind cross-over study on the efficacy of clomipramine (Anafranil) in patients with painful mono- and polyneuropathies.

Authors:  H D Langohr; M Stöhr; F Petruch
Journal:  Eur Neurol       Date:  1982       Impact factor: 1.710

5.  Resting and K+-evoked release of serotonin and norephinephrine in vivo from the rat and cat spinal cord.

Authors:  T L Yaksh; G M Tyce
Journal:  Brain Res       Date:  1980-06-16       Impact factor: 3.252

6.  Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants.

Authors:  F Borsini; C Bendotti; V Velkov; R Rech; R Samanin
Journal:  J Pharm Pharmacol       Date:  1981-01       Impact factor: 3.765

7.  beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms.

Authors:  S C Risch
Journal:  Biol Psychiatry       Date:  1982-10       Impact factor: 13.382

8.  Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment.

Authors:  T Reisine; P Soubrie
Journal:  Eur J Pharmacol       Date:  1982-01-08       Impact factor: 4.432

9.  Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats.

Authors:  A Eschalier; J L Montastruc; J L Devoize; F Rigal; G Gaillard-Plaza; J C Pechadre
Journal:  Eur J Pharmacol       Date:  1981-08-27       Impact factor: 4.432

10.  Blockade of endogenous opiates reduces activity in the rat.

Authors:  J M Walker; G G Berntson; T S Paulucci; T C Champney
Journal:  Pharmacol Biochem Behav       Date:  1981-01       Impact factor: 3.533

View more
  9 in total

Review 1.  Forced swimming test in mice: a review of antidepressant activity.

Authors:  Benoit Petit-Demouliere; Franck Chenu; Michel Bourin
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

2.  Noradrenergic and opioid mediation of tricyclic-induced reversal of escape deficits caused by inescapable shock pretreatment in rats.

Authors:  P Martin; P Soubrié; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Authors:  Liting Deng; Wan-Hung Lee; Zhili Xu; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2016-10-20       Impact factor: 7.658

Review 4.  Is the forced swimming test a suitable model for revealing antidepressant activity?

Authors:  F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 5.  Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.

Authors:  Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2011-02-24       Impact factor: 6.505

6.  Potentiation by TRH of the effect of antidepressants in the forced-swimming test, involvement of dopaminergic and opioid systems.

Authors:  V Reny-Palasse; M Constans; R Rips
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

Review 7.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

8.  Study of the clomipramine-morphine interaction in the forced swimming test in mice.

Authors:  A Eschalier; J Fialip; O Varoquaux; M C Makambila
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

9.  The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist.

Authors:  M M Gassaway; M-L Rives; A C Kruegel; J A Javitch; D Sames
Journal:  Transl Psychiatry       Date:  2014-07-15       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.